Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy bioAffinity Technologies stock
Learn how to buy bioAffinity Technologies stock in 5 easy steps.
bioAffinity Technologies is a diagnostics & research business based in the US. bioAffinity Technologies shares (BIAF) are listed on the NASDAQ and all prices are listed in US Dollars. bioAffinity Technologies employs 11 staff and has a trailing 12-month revenue of around $2,457.
How to buy bioAffinity Technologies stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BIAF. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
bioAffinity Technologies stock price (NASDAQ: BIAF)Use our graph to track the performance of BIAF stocks over time.
bioAffinity Technologies shares at a glance
|Latest market close||$1.68|
|52-week range||$1.31 - $15.55|
|50-day moving average||$1.97|
|200-day moving average||$2.57|
|Wall St. target price||N/A|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-4.21|
Buy bioAffinity Technologies stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy bioAffinity Technologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
bioAffinity Technologies price performance over time
Historical closes compared with the close of $1.68 from 2023-03-17
|1 week (2023-03-13)||-1.18%|
|1 month (2023-02-17)||-18.45%|
|3 months (2022-12-20)||-2.89%|
|6 months (2022-09-20)||-54.22%|
|1 year (2022-03-16)||N/A|
|2 years (2021-03-16)||N/A|
|3 years (2020-03-16)||N/A|
|5 years (2018-03-16)||N/A|
bioAffinity Technologies financials
|Gross profit TTM||$0|
|Return on assets TTM||-26.42%|
|Return on equity TTM||-2530.31%|
|Market capitalisation||$14.1 million|
TTM: trailing 12 months
bioAffinity Technologies share dividends
We're not expecting bioAffinity Technologies to pay a dividend over the next 12 months.
bioAffinity Technologies overview
bioAffinity Technologies, Inc. , a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas. .
Frequently asked questionsWhat percentage of bioAffinity Technologies is owned by insiders or institutions?
Currently 27.556% of bioAffinity Technologies shares are held by insiders and 1.033% by institutions. How many people work for bioAffinity Technologies?
Latest data suggests 11 work at bioAffinity Technologies. When does the fiscal year end for bioAffinity Technologies?
bioAffinity Technologies's fiscal year ends in December. Where is bioAffinity Technologies based?
bioAffinity Technologies's address is: 22211 West Interstate 10, San Antonio, TX, United States, 78257
More guides on Finder
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert